CIK 0001376339
- Large accelerated filer
MIMEDX GROUP, INC.
Sign in to watch- Ticker
- MDXG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 262792552
- Phone
- +1 770-651-9100
- Business address
- 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
- Former names
- Alynx, Co.
- 4 Open-market sale Chief Financial Officer sold 5,976 shares at $5.93 ($35,414)
- 4 Open-market sale President, Regenerative Med. sold 51,756 shares at $5.34 ($276,470)
- 4 Open-market sale Chief Accounting Officer sold 5,200 shares at $3.80 ($19,739)
- 4 Open-market sale Chief Accounting Officer sold 1,628 shares at $3.74 ($6,095)
- 4 Open-market sale President, Regenerative Med. sold 5,987 shares at $3.74 ($22,415)
- 4 Open-market sale General Counsel and CAO sold 5,988 shares at $3.74 ($22,419)
- 4 Open-market sale Chief Financial Officer sold 6,094 shares at $3.74 ($22,816)
- 4 Open-market sale Chief Accounting Officer sold 1,632 shares at $3.31 ($5,402)
- 4 Open-market sale President, Regenerative Med. sold 5,996 shares at $3.31 ($19,847)
- 4 Open-market sale General Counsel and CAO sold 5,995 shares at $3.31 ($19,843)
- 4 Open-market sale Chief Financial Officer sold 6,100 shares at $3.31 ($20,191)
- 4 Grant or award President, Regenerative Med. acquired 135,065 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 140,455 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 53,030 shares (grant or award)
- 4 Grant or award General Counsel and CAO acquired 136,364 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 462,857 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, Regenerative Med. sold 12,355 shares at $4.24 ($52,442)
- 4 Open-market sale Chief Accounting Officer sold 3,396 shares at $4.24 ($14,415)
- 4 Open-market sale Chief Financial Officer sold 12,056 shares at $4.24 ($51,173)
Page 5 of 30 · 584 filings